Digital How biotech can leverage scientific enterprise SaaS By considering how to build a solid data foundation from the beginnings, smaller start-ups or biotechs can make sure they are ready to go.
Digital Cyber resilience: Protecting tomorrow's therapies before the... As investors place increasing emphasis on operational maturity alongside scientific excellence, cyber resilience must become part of the conversation.
Market Access Approval designed from day one: Building global-ready regula... The global pharmaceutical landscape is increasingly defined by the necessity for clinical acceleration without compromising data integrity.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.